Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery

J Cardiothorac Vasc Anesth. 2002 Oct;16(5):615-6. doi: 10.1053/jcan.2002.126927.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Coronary Artery Bypass*
  • Factor VIIa / therapeutic use*
  • Humans
  • Male
  • Postoperative Hemorrhage / drug therapy*
  • Recombinant Proteins / therapeutic use
  • Reoperation

Substances

  • Recombinant Proteins
  • Factor VIIa